Somatostatin

Supplement

Somatostatin is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for somatostatin is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Supplement
Suggested cadence
once daily

Research behind this entry

  1. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. Sheppard M, Shapiro B, Pimstone B, Kronheim S, Berelowitz M, Gregory M · The Journal of clinical endocrinology and metabolism, 1979 DOI

    This citation reports a human primary study involving Somatostatin. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.

1 published study referenced in the app, each with a plain-language summary.